Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Escalon Medical Corp. (ESMC) had Revenue of $3.59M for the most recently reported fiscal quarter, ending 2025-12-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-12-31

Income Statement Financials
Revenue	$3.59M
Net Income	$0.04M
Cost of Goods Sold	$2.04M
Gross Profit	$1.56M
Operating Expenses	$3.49M
Operating Income	$0.10M
Non-Operating Income/Expense	$-0.00M
Pre-Tax Income	$0.10M
Normalized Pre-Tax Income	$0.10M
Income after Taxes	$0.10M
Income from Continuous Operations	$0.10M
Consolidated Net Income/Loss	$0.10M
Normalized Income after Taxes	$0.10M
EBIT	$0.10M
EBITDA	$0.11M
Weighted-Average Shares Outstanding (Basic)	7.42M
Weighted-Average Shares Outstanding (Diluted)	14.42M
Earnings per Share (EPS) (Basic)	$0.01
Earnings per Share (EPS) (Diluted)	$0.01
Balance Sheet Financials
Current Assets	$4.29M
Property, Plant, and Equipment	$0.03M
Long-Term Assets	$0.69M
Total Assets	$4.98M
Current Liabilities	$2.60M
Long-Term Debt	$0.14M
Long-Term Liabilities	$0.60M
Total Liabilities	$3.21M
Common Equity	$1.13M
Tangible Shareholders Equity	$1.75M
Shareholders Equity	$1.77M
Common Shares Outstanding	7.42M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-0.43M
Cash Flow from Investing Activities	$-0.00M
Cash Flow from Financial Activities	$-0.03M
Beginning Cash	$0.80M
End Cash	$0.34M
Increase/Decrease in Cash	$-0.47M
Stock-Based Compensation	--
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.65
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.07
Debt to Equity Ratio	0.14
Gross Margin	43.33%
Operating Margin	2.75%
EBIT Margin	2.75%
EBITDA Margin	--
Pre-Tax Profit Margin	2.72%
Profit Margin	1.22%
Free Cash Flow	$-0.44M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.72
Inventory Turnover	1.33
Receiveable Turnover	1.60
Days Sales in Receivables	56.07
Return on Equity	8.66%
Return on Tangible Equity	5.57%
Return on Assets	1.96%
Return on Investments	5.11%
Book Value Per Share	$0.24
Free Cash Flow per Share	$-0.03
Operating Cash Flow per Share	$-0.03

Data from Zacks Investment Research, Inc.